Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Mazzaferri F, Mirandola M, Savoldi A, De Nardo P, Morra M, Tebon M, Armellini M, De Luca G, Calandrino L, Sasset L, D'Elia D, Sozio E, Danese E, Gibellini D, Monne I, Scroccaro G, Magrini N, Cattelan A, Tascini C; MANTICO Working Group; Tacconelli E. Mazzaferri F, et al. Among authors: armellini m. Elife. 2022 Nov 22;11:e79639. doi: 10.7554/eLife.79639. Elife. 2022. PMID: 36413383 Free PMC article. Clinical Trial.
A Digital Approach to Improve Infection Screening Among Solid Organ Transplant Candidates.
Righi E, Visentin A, Mirandola M, Rigo C, Cutone C, Rocchi M, Bonato L, Armellini M, Caletti C, Onorati F, Biagio LS, Luciani GB, Mazzeo G, Merighi M, Vantini G, Borin A, Boschiero L, Carraro A, Tacconelli E. Righi E, et al. Among authors: armellini m. Clin Transplant. 2024 Jul;38(7):e15408. doi: 10.1111/ctr.15408. Clin Transplant. 2024. PMID: 39044662
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
Incorporating ethics into infectious disease clinical practice guidelines.
Righi E, Yahav D, Nasim A, Akova M, Barac A, Scudeller L, Nagavci B, Armellini M, Zanchi C, Shirin N, Tunali V, Paño-Pardo JR, Rodríguez-Baño J, Jamrozik E; ESCMID OPENING Project Group. Righi E, et al. Among authors: armellini m. Clin Microbiol Infect. 2025 Apr;31(4):560-567. doi: 10.1016/j.cmi.2025.01.008. Epub 2025 Jan 17. Clin Microbiol Infect. 2025. PMID: 39827993 Review.
Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes.
Chianelli M, Armellini M, Carpentieri M, Coccaro C, Cuttica CM, Fusco A, Marucci S, Nelva A, Nizzoli M, Ponziani MC, Sciaraffia M, Tassone F, Busetto L. Chianelli M, et al. Among authors: armellini m. Endocr Metab Immune Disord Drug Targets. 2025;25(1):8-36. doi: 10.2174/0118715303282327240507184902. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 38778593 Free PMC article. Review.
13 results